The US biotech firm Incyte is still in the process of setting up shop in Denmark and the Nordics, but it plans to grow in the coming years. The company is already growing in size both in and outside of the US, according to Incyte's General Manager Erik Fromm, who currently leads 12 employees across the Nordics.
"If all of Incyte's plans relating to new approvals and clinical studies run as planned, the idea is for us to be twice as many employees in the Nordic unit in the foreseeable future both in terms of commercial functions and research and development," he tells MedWatch.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.